Dr Reddy to sell its Rights of Anti-cancer Agent to Citius Pharma
Dr. Reddy Laboratories has sold all rights to E7777 (an engineered IL-2-diphtheria toxin fusion protein) and various related assets to
Read moreDr. Reddy Laboratories has sold all rights to E7777 (an engineered IL-2-diphtheria toxin fusion protein) and various related assets to
Read more